Onconova’s Public Debut: What You’ll Want to Know
Long Ideas - On Thursday, July 25th, Onconova Therapeutics (ONTX) makes its debut on the NASDAQ Global Market as the 27th biotech IPO of 2013. It’s been a … Continue Reading
Read nowMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Even at All-Time Highs, Illumina’s Q2 Results Support Continued Upside
Long Ideas - Since we initiated in-depth coverage of Illumina (ILMN) on November 1, 2012, shares of the gene sequencing company have soared over 66% through the close … Continue Reading
Read nowFour Months After IPO, Enanta Pharmaceuticals Carries A Compelling Valuation Next to Hepatitis Peers
Long Ideas - Since making their market debut in March, shares of Enanta Pharmaceuticals (ENTA) have remained virtually flat, excluding a post-IPO pop (shares closed at $17.18 on … Continue Reading
Read nowPositive for Ironwood is Positive for Synergy
Long Ideas - Ironwood Pharmaceuticals (IRWD) reported 2Q earnings on Tuesday morning, trouncing analyst estimates for sales of Linzess and assuaging a major overhang on the stock. The … Continue Reading
Read nowTengion: A Value Trap of Epic Proportions
Most Popular - At the end of June, biotech giant Celgene (CELG) made a $15M investment in a small and obscure biotech for the right-of-first-negotiation to one of its lead … Continue Reading
Read nowHere Are Some of PropThink’s Top Healthcare Investments from The Last Week
Long Ideas - Curis (CRIS) has been around for quite some time with little to show for it but a significant long-term loss and some dud product candidates. … Continue Reading
Read nowDon’t Be Fooled By Celsion’s Latest Rally
Insights - Celsion (CLSN) has issued a glowing but arguably immaterial press release reminding investors that, yes, there is another company on earth that has a small … Continue Reading
Read now